A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-25.89%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
Cap. Flow
-$40.2M
Cap. Flow %
-26.72%
Top 10 Hldgs %
96.37%
Holding
16
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$6.47M

Top Sells

1
TARA icon
Protara Therapeutics
TARA
$46.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PSNL icon
1
Personalis
PSNL
$434M
$43.6M 28.95% 5,449,294 – –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$30.8M 20.47% 1,203,135 – –
CRSP icon
3
CRISPR Therapeutics
CRSP
$4.71B
$22M 14.58% 519,198 – –
SLNO icon
4
Soleno Therapeutics
SLNO
$3.6B
$15.7M 10.41% 6,969,272 – –
XCUR icon
5
Exicure
XCUR
$35.4M
$10.2M 6.76% 6,977,000 – –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$8.59M 5.7% 876,541 +659,874 +305% +$6.47M
SIEN
7
DELISTED
Sientra, Inc.
SIEN
$4.69M 3.11% 2,390,843 – –
VRNA
8
Verona Pharma
VRNA
$9.16B
$3.72M 2.47% 901,943 – –
PRTK
9
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.24M 2.15% 1,041,131 – –
MTEM
10
DELISTED
Molecular Templates, Inc.
MTEM
$2.64M 1.75% 200,000 – –
TARA icon
11
Protara Therapeutics
TARA
$120M
$2.62M 1.74% 113,919 -2,030,598 -95% -$46.7M
CHMA
12
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.35M 0.89% 370,671 – –
SYRE icon
13
Spyre Therapeutics
SYRE
$996M
$1.1M 0.73% 240,500 – –
OBSV
14
DELISTED
ObsEva SA Ordinary Shares
OBSV
$210K 0.14% 87,999 – –
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
$191K 0.13% 131,036 – –
OCGN icon
16
Ocugen
OCGN
$319M
$2K ﹤0.01% 7,111 – –